1. Efficacy and biomarker analysis of nivolumab plus gemcitabine and cisplatin in patients with unresectable or metastatic biliary tract cancers: results from a phase II study. Issue 1 (2nd June 2020) Authors: Feng, Kaichao; Liu, Yang; Zhao, Yongtian; Yang, Qingming; Dong, Liang; Liu, Jiejie; Li, Xiang; Zhao, Zhikun; Mei, Qian; Han, Weidong Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma. Issue 4 (5th April 2021) Authors: Liu, Yang; Wang, Chunmeng; Li, Xiang; Dong, Liang; Yang, Qingming; Chen, Meixia; Shi, Fengxia; Brock, Malcolm; Liu, Miao; Mei, Qian; Liu, Jiejie; Nie, Jing; Han, Weidong Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers. Issue 10 (14th July 2017) Authors: Feng, Kaichao; Liu, Yang; Guo, Yelei; Qiu, Jingdan; Wu, Zhiqiang; Dai, Hanren; Yang, Qingming; Wang, Yao; Han, Weidong Journal: Protein & cell Issue: Volume 9:Issue 10(2018) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Proceedings of the 2016 China Cancer Immunotherapy Workshop. Issue 1 (October 2016) Authors: Xue, Bin; Xu, Jiaqi; Song, Wenru; Yang, Zhimin; Liu, Ke; Li, Zihai; Li, Zihai; Chen, Lieping; Garon, Edward; Hu-Lieskovan, Siwen; Ding, Wei; Pan, Chong-Xian; Sun, Weijing; Liu, Yong-Jun; Zheng, Lei; Liu, Delong; Sadelain, Michel; Yee, Cassian; Wang, Rongfu; Chen, Meixia Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗